Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what’s been a flurry of acquisitions at a similar price point.
Trending
- Why El Salvador Is Becoming A Global Crypto Licensing Hub (and How Your Company Can Benefit)
- CoinPoker Debuts New App With Rake Free Poker, Signs Abby Merk And Papo MC
- Crypto Market Review: Is Bitcoin (BTC) Bull Mode Switched On? XRP Looks Hopeless at $1, Solana (SOL) Heads to $95 in Surprising Mini-Bull Run
- Flow Shares Ecosystem Update; Announces Joint Resolution with Binance
- Market Update: RY, THO, TOL, DASH
- Gold Pares Losses as Dollar Weakens After Trump Remarks on War
- Strengthening Digital Trust In The Crypto Era
- Is The XRP Ledger Quantum Ready?
News
categories
useful link
© 2026 cryptaces.